Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020

Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)BOULDER, Colo., Dec. 4, 2017 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) (“Array” or the “Company”) today announced that it has called for redemption approximately $6.2 million of its 3.00% Convertible Senior Notes due 2020 (the “2020 Notes”) representing all remaining 2020 Notes…



TravelWireNews Chatroom for Readers (join us)

%d bloggers like this: